Pulmonary Blastomycosis

ABSTRACT

Blastomycosis is a rare but important fungal infection diagnosed primarily in the south central and midwestern United States but also in the American and Canadian borders of the Great Lakes. Epidemics of infection related to point-source exposure include patients of all ages and both sexes, but endemic cases are usually in young to middle-aged adults, with more men than women reported. Pneumonia is the most common manifestation and the lung is almost always the organ initially infected. The lung manifestations range from illness that mimics acute bacterial pneumonia to chronic, destructive lung disease appearing like tuberculosis or lung cancer. Extrapulmonary disease can occur with or without concomitant lung disease. In descending order, cutaneous, osseous, prostatic, and central nervous system involvements are the most frequent manifestations of extrapulmonary blastomycosis. Amphotericin B is curative, but, because of toxicity, oral azole agents have replaced amphotericin B as therapy for less than overwhelming blastomycosis. Itraconazole is now considered to be the agent of choice with fluconazole, voriconazole, and posaconazole having a role in selected patients. In a patient with life-threatening or central nervous system blastomycosis amphotericin B should be given, at least initially.

KEYWORDS

Blastomycosis; Blastomyces dermatitidis; lung diseases - fungal

REFERENCES

• 1 Sarosi G A, Davies S F. Blastomycosis. State of the art.  Am Rev Respir Dis. 1979;  120 911-938
• 2 Bradsher R W, Chapman S W, Pappas P G. Blastomycosis.  Infect Dis Clin North Am. 2003;  17 21-40
• 3 Gilchrist T C. Protozoan dermatitis.  J Cutan Gen Dis. 1894;  12 496-499
• 4 Gilchrist T C, Stokes W R. Case of pseudo-lupus vulgaris caused by Blastomyces .  J Exp Med. 1898;  3 53-78
• 5 Witorsch P, Utz J P. North American blastomycosis: a study of 40 patients.  Medicine. 1968;  47 169-200
• 6 Kwon-Chong K J, Bennett J E. Blastomycosis. In: Medical Mycology. Philadelphia; Lea & Febiger 1992: 248-279
• 7 Kaufman L, Standard P G, Weeks R J et al.. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis.  J Clin Microbiol. 1983;  18 110-114
• 8 Medoff G, Painter A, Kobayashi G S. Mycelial to yeast-phase transitions of the dimorphic fungi Blastomyces dermatitidis and Paracoccidioides brasiliensis .  J Bacteriol. 1987;  169 4055-4060
• 9 Kaufman L, Standard P G. Specific and rapid identification of medically important fungi by exoantigen detection.  Annu Rev Microbiol. 1987;  41 209-225
• 10 Stockman L, Clark K A, Hunt J M et al.. Evaluation of commercially available acridine ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans and Histoplasma capsulatum .  J Clin Microbiol. 1993;  31 845-850
• 11 Sugar A M, Picard M. Macrophage- and oxidant-mediated inhibition of the ability of live Blastomyces dermatitidis conidia to transform to the pathogenic yeast phase; implications for the pathogenesis of dimorphic fungal infections.  J Infect Dis. 1991;  163 371-375
• 12 Bradsher R W. Blastomycosis.  Infect Dis Clin North Am. 1988;  2 877-898
• 13 Bradsher R W, Martin M R, Wilkes T D, Waltman C, Bolyard K. Unusual presentations of blastomycosis: ten case summaries.  Infect Med. 1990;  7 10-19
• 14 Landis F B, Varkey B. Late relapse of pulmonary blastomycosis after adequate treatment with amphotericin B.  Am Rev Respir Dis. 1976;  113 77-81
• 15 Laskey W, Sarosi G A. Endogenous activation in blastomycosis.  Ann Intern Med. 1978;  88 50-52
• 16 Furcolow M L, Chick E W, Busey J F et al.. Prevalence and incidence studies of human and canine blastomycosis, I: Cases in the United States, 1885-1968.  Am Rev Respir Dis. 1970;  102 60-67
• 17 Furcolow M L, Busey J F, Menges R W et al.. Prevalence and incidence studies of human and canine blastomycosis, II: Yearly incidence studies in three states, 1960-1967.  Am J Epidemiol. 1970;  92 121-131
• 18 Taxy J B. Blastomycosis: contributions of morphology to diagnosis.  Am J Surg Pathol. 2007;  31 615-623
• 19 Baumgardner D J, Buggy B P, Mattson B J, Burdick J S, Ludwig D. Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin.  Clin Infect Dis. 1992;  15 629-635
• 20 Crampton T L, Light R B, Berg G M et al.. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals.  Clin Infect Dis. 2002;  34 1310-1316
• 21 Baumgardner D J, Knavel E M, Steber D, Swain G R. Geographic distribution of human blastomycosis cases in Milwaukee, Wisconsin, USA.  Mycopathologia. 2006;  161 275-282
• 22 Klein B S, Vergeront J M, Weeks R J et al.. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin.  N Engl J Med. 1986;  314 529-534
• 23 Klein B S, Vergeront J M, DiSalvo A F et al.. Two outbreaks of blastomycosis along rivers in Wisconsin: isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways.  Am Rev Respir Dis. 1987;  136 1333-1338
• 24 Bradsher R W. Water and blastomycosis: don't blame beaver.  Am Rev Respir Dis. 1987;  136 1324-1326
• 25 Pappas P G, Pottage J C, Powderly W G et al.. Blastomycosis in patients with the acquired immunodeficiency syndrome.  Ann Intern Med. 1992;  116 847-853
• 26 Cox R A, Larsh H W. Yeast and mycelial-phase antigens of Blastomyces dermatitidis: comparison using disc gel electrophoresis.  Infect Immun. 1974;  10 48-53
• 27 Cox R A, Larsh H W. Isolation of skin test-active preparations from yeast-phase cells of Blastomyces dermatitidis .  Infect Immun. 1974;  10 42-47
• 28 Bradsher R W, Alford R H. Blastomyces dermatitidis antigen-induced lymphocyte reactivity in human blastomycosis.  Infect Immun. 1981;  33 485-490
• 29 Vaaler A K, Bradsher R W, Davies S F. Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin.  Am J Med. 1990;  89 470-475
• 30 Wüthrich M, Filutowicz H I, Allen H L, Deepe G S, Klein B S. Vβ1 ⁺ Jβ1.1 ⁺ /Vα2 ⁺ Jα49 ⁺ CD₄ ⁺ T cells mediate resistance against infection with Blastomyces dermatitidis .  Infect Immun. 2007;  75 193-200
• 31 Sarosi G A, Eckman M R, Davies S F, Laskey W K. Canine blastomycosis as a harbinger of human disease.  Ann Intern Med. 1979;  91 733-735
• 32 Steele R W, Abernathy R A. Systemic blastomycosis in children.  Pediatr Infect Dis. 1983;  2 304-307
• 33 Bradsher R W, Rice D C, Abernathy R S. Ketoconazole therapy of endemic blastomycosis.  Ann Intern Med. 1985;  103 872-879
• 34 Halvorsen R A, Duncan J D, Merten D F, Gallis H A, Putman C E. Pulmonary blastomycosis.  Radiology. 1984;  150 1-5
• 35 Kinasewitz G T, Penn R L, George R B. The spectrum and significance of pleural disease in blastomycosis.  Chest. 1984;  86 580-584
• 36 Evans M E, Haynes J B, Atkins J B, Atkinson J B, Delvaux Jr T C, Kaiser A B. Blastomyces dermatitidis and the adult respiratory distress syndrome.  Am Rev Respir Dis. 1982;  126 1099-1102
• 37 Meyer K C, McManus E J, Maki D G. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome.  N Engl J Med. 1993;  329 1231-1236
• 38 Skillrud D M, Douglas W W. Survival in ARDS caused by blastomycosis infection.  Mayo Clin Proc. 1985;  60 266-269
• 39 Maioriello R P, Merwin C F. North American blastomycosis presenting as an acute panniculitis and arthritis.  Arch Dermatol. 1970;  102 92-96
• 40 Suen J Y, Wetmore S J, Wetzel W J. Blastomycosis of the larynx.  Ann Oto Rhinol Laryngol. 1980;  89 563-566
• 41 Farmer C, Stanley M W, Bardales R H et al.. Mycoses of the breast: diagnosis by fine needle aspiration.  Diagn Cytopathol. 1995;  12 51-55
• 42 Pappas P G, Threlkeld M G, Bedsole G D, Cleveland K O, Gelfand M S, Dismukes W E. Blastomycosis in immunocompromised patients.  Medicine. 1993;  72 311-325
• 43 Klein B S, Vergeront J M, Kaufman L et al.. Serologic tests for blastomycosis: assessment during a large point source outbreak in Wisconsin.  J Infect Dis. 1987;  155 262-268
• 44 Klein B S, Jones J M. Isolation, purification, and radio-labeling of a novel 120KD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients.  J Clin Invest. 1990;  85 152-161
• 45 Durkin M, Witt J, LeMonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis.  J Clin Microbiol. 2004;  42 4873-4875
• 46 Sarosi G A, Davies S F, Phillips J R. Self-limited blastomycosis: a report of 39 cases.  Semin Respir Infect. 1986;  1 40-44
• 47 Recht L D, Phillips J R, Eckman M R, Sarosi G A. Self-limited blastomycosis: a report of thirteen cases.  Am Rev Respir Dis. 1979;  120 1109-1112
• 48 Chapman S W, Bradsher R W, Campbell G D, Pappas P G, Kauffman C A. Practice guidelines for the management of patients with blastomycosis.  Clin Infect Dis. 2000;  30 679-683
• 49 Dismukes W E, Bradsher R W, Cloud G C et al.. Itraconazole therapy for blastomycosis and histoplasmosis.  Am J Med. 1992;  93 489-497
• 50 Pappas P G, Bradsher R W, Chapman S W et al.. Treatment of blastomycosis with fluconazole: a pilot study.  Clin Infect Dis. 1995;  20 267-271
• 51 Pappas P G, Bradsher R W, Kauffman C A et al.. Treatment of blastomycosis with higher doses of fluconazole.  Clin Infect Dis. 1997;  25 200-205
• 52 Bariola J R, Perry P M, Pappas P G, Bradsher R W. Central nervous system (CNS) blastomycosis: review of recent experience. Program Abstract, Infectious Diseases Society of America 45th Annual Meeting October 5, 2007 San Diego, CA;